Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$61,737,022
+$1,574,296 QoQ
Shares Held
393,932
+0.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
1.69%
of 13F equity value
Holder Rank
#47
of 1,603 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TCTC Holdings, LLC holds $213,213,164 across 9 Drug Manufacturers - General names. NVS ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
393,932 | $61,737,022 | |
| 2 | ABBV |
AbbVie Inc.
|
134,017 | $33,724,036 | |
| 3 | PFE |
Pfizer Inc
|
1,234,102 | $29,717,175 | |
| 4 | MRK |
Merck & Co., Inc.
|
207,881 | $26,712,708 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
388,238 | $22,370,273 | |
| 6 | JNJ |
Johnson & Johnson
|
59,310 | $15,062,960 | |
| 7 | AMGN |
Amgen Inc
|
32,646 | $11,821,768 | |
| 8 | LLY |
ELI LILLY & Co
|
9,733 | $11,674,052 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,737,022 | 393,932 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $60,162,726 | 393,864 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $54,333,049 | 394,089 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $50,197,752 | 391,436 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $47,391,872 | 391,636 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $43,674,185 | 391,767 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $38,407,283 | 394,690 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $45,434,279 | 395,012 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $42,107,059 | 395,520 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $38,527,655 | 398,301 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $40,273,802 | 398,869 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $40,624,416 | 398,826 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $40,376,714 | 400,126 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $36,811,592 | 400,126 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $36,250,169 | 399,583 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $30,208,881 | 397,433 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $33,817,663 | 400,067 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $35,307,616 | 402,366 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $35,305,690 | 403,632 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $32,940,247 | 402,791 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $37,054,753 | 406,124 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $34,559,820 | 404,303 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $38,224,129 | 404,788 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $35,276,453 | 405,663 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $35,214,614 | 403,190 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||